An email has been sent to your address with instructions for changing your password.
There is no user registered with this email.
Sign Up
To create a free account, please fill out the form below.
Thank you for signing up!
A confirmation email has been sent to your email address. Please check your email and follow the instructions in the message to complete the registration process. If you do not receive the email, please check your spam folder or contact us for assistance.
Welcome to our platform!
Oops!
Something went wrong while trying to create your new account. Please try again and if the problem persist, Email Us to receive support.
Enfusion Welcomes New Addition to Board of Directors
Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Very Positive)
Tags
management
Deirdre Somers joins as new member of Enfusion’s Audit and Nominating and Corporate Governance Committees
NEW YORK & LONDON & HONG KONG--(BUSINESS WIRE)--
Enfusion, Inc. (NYSE: ENFN), a leading provider of cloud-native SaaS solutions for investment managers, today announced the appointment of global asset management and financial industry veteran Deirdre Somers to its Board of Directors, effective January 1, 2023. As part of her role, she will sit on the Audit and the Nominating and Corporate Governance Committees.
“I am delighted to be joining the Board at Enfusion,” said Somers. “It will be a privilege to support a great company delivering great technology at an interesting time in asset management globally.”
Based in Dublin, Ireland, Somers brings with her more than 30 years of experience in asset management, as the former CEO of a securities exchange and as an independent non-executive director, committee member, and chairman. She has both international experience and industry knowledge in financial products, market structure, and EU regulation as well as in corporate actions and public market transitions. Somers is currently an independent non-executive director (INED) and committee member of Aquis Exchange PLC, Blackrock iShares, Cancer Trials Ireland (Chair), Episode Inc, and Kenmare Resources plc.
“We are pleased to welcome Deirdre, and the significant experience she brings to Enfusion’s leadership team,” said Interim Chair of the Board, Kathleen DeRose. “We appreciate her global perspective and depth of financial markets expertise and look forward to working with Deirdre as we continue to build Enfusion’s global footprint within the investment management industry.”
"I am incredibly excited to welcome Mrs. Somers to Enfusion's Board of Directors. Deirdre brings with her an impressive operating, governance and oversight track record in the capital markets industry. I look forward to working closely with Deirdre as she broadens diversity and scope of skill sets and views at the Board level that will make an undeniable positive impact on Enfusion’s ability to scale globally.” said Oleg Movchan, Interim Chief Executive Officer and a Member of the Board of Directors.
Enfusion’s existing board of directors includes Brad Bernstein, Chairman Kathleen DeRose, Jan Hauser, Larry Leibowitz, Roy Luo, and Oleg Movchan.
About Enfusion
Enfusion's investment management software-as-a-service platform removes traditional information boundaries, uniting front-, middle- and back-office teams on one cloud-native system. Through its software, analytics, and middle/back-office managed services, Enfusion creates enterprise-wide cultures of real-time, data-driven intelligence, boosting agility, and powering growth. Enfusion partners with over 800 investment managers from 10 global offices spanning four continents.
enfusion is the leading provider of a cloud-based portfolio management and risk system. headquartered in chicago, illinois, with a branch office in new york, new york, and wholly-owned subsidiaries in london and hong kong, enfusion is a software company that focuses on delivering innovative solutions for clients in the financial services industry. our clients across the globe rely on our innovative real-time performance, risk calculations and accounting for some of the most sophisticated financial products. enfusion is undergoing exceptional growth and currently serves some of the world's largest and respected hedge funds with over 90 billion dollars of assets under management.
